Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
fda
life sciences
national
5
×
national blog main
novartis
5
×
national top stories
new york top stories
san francisco top stories
biogen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
gene therapy
genentech
indiana blog main
indiana top stories
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
eli lilly
europe top stories
ipo
zolgensma
10x genomics
abbvie
What
fda
5
×
new
bio
drug
medicines
roundup
therapy
won
activity
amgen
approval
approvals
approved
atrophy
august
biogen
biotech
busy
candidates
chemistry
clamped
class
cmc
consistent
controls
covid
daily
days
decisions
delays
developed
developing
devices
drugs
economic
ensure
evrysdi
fast
friday
gene
Language
unset
Current search:
national
×
fda
×
novartis
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines